We are live on ! Find out more
KBC Group

KBC Group Portfolio holdings

AUM $39.9B
1-Year Est. Return 29.7%
This Fund
S&P 500
This Quarter Est. Return
+13.27%
1 Year Est. Return
+29.7%
3 Year Est. Return
+99.77%
5 Year Est. Return
+133.11%
10 Year Est. Return
+496.57%
AUM
$28.2B
AUM Growth
+$3.7B
Cap. Flow
+$629M
Cap. Flow %
2.23%
Top 10 Hldgs %
27.98%
Holding
1,934
New
25
Increased
581
Reduced
466
Closed
75

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$117M
2
MSFT icon
Microsoft
MSFT
+$84.2M
3
AVGO icon
Broadcom
AVGO
+$71.8M
4
BMY icon
Bristol-Myers Squibb
BMY
+$71.8M
5
CTSH icon
Cognizant
CTSH
+$60.7M

Top Sells

Rank Stock Value
1
MRSH
Marsh
MRSH
+$65.7M
2
AFL icon
Aflac
AFL
+$54.1M
3
HUM icon
Humana
HUM
+$54M
4
ZTS icon
Zoetis
ZTS
+$48.3M
5
PNC icon
PNC Financial Services
PNC
+$44.4M

Sector Composition

Rank Sector Weight
1 Technology 34.43%
2 Healthcare 16.09%
3 Financials 12.41%
4 Consumer Discretionary 10.83%
5 Communication Services 7.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NFLX icon
51
Netflix
NFLX
$305B
$118M 0.42%
2,422,880
+20,680
+0.9% +$903K
CDNS icon
52
Cadence Design Systems
CDNS
$91.7B
$117M 0.42%
431,365
-1,815
-0.4% -$468K
ELV icon
53
Elevance Health
ELV
$81.6B
$117M 0.42%
248,376
+21,291
+9% +$9.85M
GILD icon
54
Gilead Sciences
GILD
$163B
$115M 0.41%
1,421,560
+184,805
+15% +$14.4M
ADSK icon
55
Autodesk
ADSK
$49.6B
$114M 0.41%
470,017
-5,392
-1% -$1.16M
XOM icon
56
ExxonMobil
XOM
$651B
$114M 0.4%
1,136,038
+82,011
+8% +$8.62M
ISRG icon
57
Intuitive Surgical
ISRG
$126B
$110M 0.39%
324,734
-70,715
-18% -$21.1M
CTSH icon
58
Cognizant
CTSH
$24.3B
$107M 0.38%
1,422,912
+878,759
+161% +$60.7M
BSX icon
59
Boston Scientific
BSX
$68.4B
$107M 0.38%
1,847,685
-339,983
-16% -$18.1M
BRK.B icon
60
Berkshire Hathaway Class B
BRK.B
$1.1T
$103M 0.36%
287,767
+10,785
+4% +$3.79M
SYK icon
61
Stryker
SYK
$133B
$101M 0.36%
337,818
-71,624
-17% -$20.1M
MDLZ icon
62
Mondelez International
MDLZ
$80.5B
$99.6M 0.35%
1,375,157
-112,917
-8% -$7.74M
HCA icon
63
HCA Healthcare
HCA
$85.7B
$99.1M 0.35%
365,984
+926
+0.3% +$229K
XYL icon
64
Xylem
XYL
$27.3B
$98.4M 0.35%
860,457
+10,647
+1% +$1.06M
FISV
65
Fiserv Inc
FISV
$28.8B
$96.9M 0.34%
729,529
+284,276
+64% +$34.9M
AOS icon
66
A.O. Smith
AOS
$8.24B
$96.7M 0.34%
1,173,179
+52,379
+5% +$3.86M
CL icon
67
Colgate-Palmolive
CL
$73.3B
$96.5M 0.34%
1,210,869
+233,163
+24% +$17.5M
ORCL icon
68
Oracle
ORCL
$367B
$93.6M 0.33%
887,392
+32,582
+4% +$3.56M
WMS icon
69
Advanced Drainage Systems
WMS
$10.5B
$92.8M 0.33%
659,483
+2,577
+0.4% +$311K
CVS icon
70
CVS Health
CVS
$134B
$90.8M 0.32%
1,149,677
-168,594
-13% -$12M
NKE icon
71
Nike
NKE
$62.7B
$86.7M 0.31%
798,309
+45,124
+6% +$4.85M
PNR icon
72
Pentair
PNR
$10.6B
$86.6M 0.31%
1,191,049
-68,582
-5% -$4.43M
AMGN icon
73
Amgen
AMGN
$209B
$86.5M 0.31%
300,173
-101,405
-25% -$27.6M
HIG icon
74
Hartford Financial Services
HIG
$39.2B
$86.4M 0.31%
1,074,470
-7,657
-0.7% -$577K
CB icon
75
Chubb
CB
$135B
$85.3M 0.3%
377,455
+13,090
+4% +$2.86M

Similar funds

KBC Group's Q4 2023 Portfolio in Review

As of Q4 2023, KBC Group held 1,934 positions worth $28.2B, up 15% from $24.5B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

KBC Group's Q4 2023 filing shows 25 new, 581 increased, 466 reduced and 75 closed positions. Its largest new stake was Veralto: 386,622 shares worth $31.8M. The largest sale was Marsh, an estimated $65.7M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 31% a quarter earlier, followed by Healthcare and Financials.

  • KBC Group's largest Q4 2023 buy was Veralto: 386,622 shares worth $31.8M.
  • KBC Group added most to NVIDIA in Q4 2023, an estimated $117M increase.
  • KBC Group's biggest Q4 2023 reduction was Marsh, cutting an estimated $65.7M.
  • KBC Group fully exited VMware, Inc in Q4 2023, selling an estimated $28.8M.
  • KBC Group's ten largest holdings make up 28% of its $28.2B portfolio in Q4 2023.
  • KBC Group opened 25 new positions and closed 75 in Q4 2023.
  • KBC Group's portfolio value rose 15% quarter-over-quarter to $28.2B.

Based on KBC Group's 13F filing for Q4 2023, filed 13 Feb 2024.